Director @AmgenOncology, ❤️ @JohnsHopkinsMBG
Joined August 2018
- Tweets 1,490
- Following 928
- Followers 1,902
- Likes 4,710
54 Photos and videos
Excited to share a new Perspective published today in @NatureCellBio, written with Colin Gliech
In this piece, we discuss how cells leverage biological “clocks” during mitosis to protect genome integrity—a fascinating layer of regulation in cell division.
nature.com/articles/s41556-0…
4
16
1,884
24 Aug 2025
I love watching Walnut come alive during the finishing process
6
524
25 May 2025
Interested in E3-Ub ligase regulation? Check out the latest paper from our lab: nature.com/articles/s41594-0…. Big congrats to @PeterYeowZY who conceived and drove this study!
2
3
28
1,703
26 May 2025
Also, check out the accompanying paper from the @oegemadesai_lab nature.com/articles/s41594-0…
5
328
Andrew Holland retweeted
5 Mar 2025
Centriole structural integrity defects are a crucial feature of hydrolethalus syndrome, say Ana Curinha (@ana_curinha), Andrew Holland @AHollandLab @JohnsHopkins and colleagues: hubs.la/Q038zmjt0
#Centrioles #Cilia
4
21
1,728
28 Feb 2025
Check out our latest work using the AID2 system to control the levels of an essential protein in mice. Congrats to the entire team, especially @SladkyValentina and Margaret Strong
science.org/doi/10.1126/scia…
1
4
41
3,467
26 Feb 2025
Check out our latest paper in @JCellBiol. Congrats to the entire team, especially @ana_curinha
26 Feb 2025
HLS, an autosomal recessive #ciliopathy, is associated with a mutation in the centriole protein HYLS1. Curinha, Holland et al @JohnsHopkins show that HYLS1 mutant mice exhibit developmental abnormalities, with #centriole integrity & #cilia assembly defects hubs.la/Q038p3mr0
3
20
2,299
Andrew Holland retweeted
11 Feb 2025
BREAKING: Johns Hopkins along with 12 peer institutions and Assoc of Amer Univ sues to stop drastic cuts in NIH funding. This is separate from lawsuit brought by 22 states, which also includes Maryland. Hopkins prez cites our 600 clinical trials that would be crippled by the cut.
137
1,432
5,579
206,792
Andrew Holland retweeted
12 Feb 2025
Things I wish more people knew about doing science in the US (thread):
15
261
689
102,387
24 Jan 2025
Three papers accepted in one week. That won’t ever happen again….
2
1
45
2,455
Andrew Holland retweeted
1 Nov 2024
Curious about how cells generate mechanically stiff invasive protrusions from branched actin filaments? Check out our paper published today in @NatureCellBio!
Congratulations to Yue Lu and all co-authors for a beautiful piece of work!
nature.com/articles/s41556-0…
8
32
146
12,370
Andrew Holland retweeted
17 Oct 2024
Mesoscale regulation of MTOCs by the E3 ligase TRIM37 dlvr.it/TFRbdj
1
2
498
Andrew Holland retweeted
10 Oct 2024
Full preprint here: biorxiv.org/content/10.1101/… we welcome feedback and questions, thanks! 🙏
1
2
518
Andrew Holland retweeted
10 Oct 2024
📝Preprint! 1️⃣Question: How are large MTOC structures regulated by an E3 ligase? 🧵In 2020, we showed TRIM37 suppresses surrogate MTOC structures in 17q23 cancers, see ⬇️). But TRIM37 also regulates centrosomes and pathological MTOCs (Gönczy/Oegema/Desai labs). How?? ➡️our model
1
2
13
1,414
Andrew Holland retweeted
10 Oct 2024
2️⃣ Model: My work at @ahollandlab suggests a shared blueprint within the TRIM family for assembly regulation. Akin to TRIM5a in HIV restriction, TRIM37 employs an assembly-driven E3 activation process but is uniquely tailored for MTOC control via its TRAF domain. ➡️Impact
1
1
3
431
Andrew Holland retweeted
14 Jun 2024
Today's @US_FDA decision to expand use of Bispecific T-cell Engager (BiTE®) immunotherapy to adult patients receiving front-line B-ALL therapy is a major milestone in the care of leukemia patients. As a hematologist who cared for patients with ALL just prior to joining @Amgen, I am well calibrated to the chance this medicine and regimen has to change the outcome for so many fighting this disease. Bravo. #MyCompany
We’re proud to announce that the @US_FDA has approved Amgen’s BiTE® immunotherapy for the treatment of CD19-positive Ph-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase.
🔗 Press release: amgen.ly/4ciz0nY
$AMGN
2
2
46
10,758
Andrew Holland retweeted
17 May 2024
Today’s @US_FDA approval is a landmark achievement in the evolution of small cell lung cancer care - demonstrating @Amgen’s continued success against the toughest cancers and reaffirming our commitment to relentlessly innovating for patients. #MyCompany
5
6
84
10,948